Other drug-induced secondary parkinsonism

PheWeb

OTHER_DRUGADVERS_SECONDA_PARKINSONI

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 G21.1#

197

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10

197

Check minimum number of events None

197

Include endpoints None

197

OTHER_DRUGADVERS_SECONDA_PARKINSONI

Extra metadata

Level in the ICD hierarchy C

First used in FinnGen datafreeze DF5

Similar endpoints

↥

List of similar endpoints to Other drug-induced secondary parkinsonism based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	192	96	96
Unadjusted prevalence (%)	0.06	0.06	0.07
Mean age at first event (years)	58.99	60.88	57.11

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: OTHER_DRUGADVERS_SECONDA_PARKINSONI – Other drug-induced secondary parkinsonism
GWS hits: 0

Survival analyses between endpoints

↥

Plot

before Other drug-induced secondary parkinsonism
after Other drug-induced secondary parkinsonism

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Other drug-induced secondary parkinsonism

↥